ERBB2 and breast carcinoma: Next, we wanted to test the effect of the combination of both HpI4 and HpI6 with trastuzumab (TZ), a humanized monoclonal antibody against HER-2 used together with chemotherapy as a standard treatment in HER-2-positive breast cancer [13].